Novel Interventions and Collaborations to Improving the Safe Use of Medications (U01)

Food and Drug Administration

Description

As part of FDA's Safe Use Initiative: Collaborating to Reduce Preventable Harm, FDA will identify drug/drug classes or therapeutic areas associated with preventable harm. The mission of the Safe use Initiative is to seek solutions to preventable harm associated with suboptimal use of regulated prescription and over the counter medications. The approach is to involve cross sector collaborations with other parts of healthcare committed to medication safety. This Funding Opportunity Announcement (FOA), issued by FDA, will provide resources for research to characterize preventable harm associated with specific FDA regulated drugs, identify sources (root causes) of the preventable harm and for the development and implementation of interventions to reduce the preventable harm.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses

Contact

Stephanie Bogan <br/>Grants Management Specialist
stephanie.bogan@fda.hhs.gov